Vivos (RDGL) Return on Sales Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos | - | - | -3,105.00 | 65.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.00 |
| Sep 30, 2025 | -227.00 |
| Jun 30, 2025 | 32.00 |
| Mar 31, 2025 | 23.00 |
| Dec 31, 2024 | -89.00 |
| Sep 30, 2024 | -152.00 |
| Dec 31, 2023 | -90.00 |
| Sep 30, 2023 | -76.00 |
| Dec 31, 2022 | 227.00 |
| Sep 30, 2022 | 41.00 |
| Dec 31, 2020 | 1,525.00 |
| Sep 30, 2020 | 845.00 |
| Dec 31, 2019 | 474.00 |
| Sep 30, 2019 | -45.00 |
| Mar 31, 2018 | -182.00 |
| Dec 31, 2017 | -832.00 |
| Sep 30, 2017 | -680.00 |
| Jun 30, 2017 | -99.00 |
| Mar 31, 2017 | -26.00 |
| Dec 31, 2016 | -786.00 |
| Sep 30, 2016 | -30.00 |
| Jun 30, 2016 | -983.00 |
| Mar 31, 2016 | -1,408.00 |
| Dec 31, 2015 | 318.00 |
| Sep 30, 2015 | -174.00 |
| Jun 30, 2015 | -586.00 |
| Mar 31, 2015 | 147.00 |
| Dec 31, 2014 | -735.00 |
| Sep 30, 2014 | -173.00 |
| Jun 30, 2014 | -108.00 |
| Mar 31, 2014 | -65.00 |
| Dec 31, 2013 | -22.00 |